Autopsy report · NCT04939584

Patient Perception of MultiPulse Therapy™ (MPT™)

“Sponsor ceased operations”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 10 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Cardialen, Inc.

Sponsor type

Industry

Conditions

Atrial Fibrillation

Interventions

MultiPulse Therapy

Participants

6

Sites

2

Countries

Australia

Trials that died the same way

• Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
  “Sponsor Terminated” (85% match in meaning)
• Magnetic Muscle Stimulation of Abdominal Muscle
  “Sponsor Discontinued due to business decision.” (81% match in meaning)
• Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
  “Sponsor terminated financial support” (80% match in meaning)
• Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
  “Loss of Financial Sponsor” (80% match in meaning)
• Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
  “Sponsor withdrew support” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.